Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

R-EPOCH regimen

View Patient Information
A regimen consisting of rituximab, followed by a continuous infusion of etoposide, vincristine and doxorubicin, given with prednisone and a bolus dose of cyclophosphamide, used for the treatment of aggressive forms of non-Hodgkin's lymphoma, including mantle cell lymphoma.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:REPOCH regimen
rituximab-EPOCH regimen
rituximab-etoposide-prednisone-Oncovin-cyclophosphamide-hydroxydaunorubicin regimen
rituximab/etoposide/prednisone/vincristine/cyclophosphamide/doxorubicin regimen
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search